Multicenter Registry Study of Endovascular Treatment for Acute Ischemic Stroke

What this Trial Is About

This research aims to observe and evaluate the outcomes of endovascular treatment for acute ischemic stroke AIS caused by vessel blockage in the brains anterior or posterior circulation. The study is a prospective, multicenter, observational trial designed to assess the safety and functional recovery of patients receiving this treatment in routine clinical settings. Participants receive endovascular treatment, which may include mechanical thrombectomy using devices such as stents, aspiration catheters, or combinations with intra-arterial clot-dissolving therapies. The study records these procedures as part of standard care without randomization or comparison groups since it is observational. During the study, researchers will track patients recovery and safety outcomes through various assessments, including a primary focus on functional improvement measured by the modified Rankin scale at 90 days. Additional measures include neurological status at 24 hours and 7 days, as well as details about blood vessel reopening immediately after and during the procedure. The study intends to provide insights into real-world treatment results and safety over the follow-up period.

Acute Ischemic Stroke EndoVascular Therapy: a Multicenter REGISTRY Study